Developing an easier-to-use formulation of apomorphine for Parkinson's disease.
Industry: Health Care
First Day Return: +4.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/15/2015 |
Offer Price | $14.00 |
Price Range $14.60 - $14.60 | |
Offer Shares (mm) | 4.5 |
Deal Size ($mm) | $63 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/17/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $63 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Toronto, Canada |
Founded | 2004 |
Employees at IPO | 17 |
Website www.cynapsustherapeutics.com |